000 | 01782 a2200481 4500 | ||
---|---|---|---|
005 | 20250515035154.0 | ||
264 | 0 | _c20070212 | |
008 | 200702s 0 0 eng d | ||
022 | _a1931-857X | ||
024 | 7 |
_a10.1152/ajprenal.00146.2006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aErdely, Aaron | |
245 | 0 | 0 |
_aDOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains. _h[electronic resource] |
260 |
_bAmerican journal of physiology. Renal physiology _cJan 2007 |
||
300 |
_aF192-6 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAnti-Bacterial Agents |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aBody Weight _xdrug effects |
650 | 0 | 4 |
_aCreatinine _xmetabolism |
650 | 0 | 4 | _aDesoxycorticosterone |
650 | 0 | 4 |
_aEnzyme Inhibitors _xtoxicity |
650 | 0 | 4 |
_aKidney Failure, Chronic _xchemically induced |
650 | 0 | 4 | _aNephrectomy |
650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 |
_aNitric Oxide Synthase Type I _xmetabolism |
650 | 0 | 4 |
_aOrgan Size _xdrug effects |
650 | 0 | 4 |
_aProteinuria _xchemically induced |
650 | 0 | 4 | _aPuromycin |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred WF |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSodium Chloride |
650 | 0 | 4 | _aSpecies Specificity |
700 | 1 | _aFreshour, Gary | |
700 | 1 | _aTain, You-Lin | |
700 | 1 | _aEngels, Kevin | |
700 | 1 | _aBaylis, Chris | |
773 | 0 |
_tAmerican journal of physiology. Renal physiology _gvol. 292 _gno. 1 _gp. F192-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajprenal.00146.2006 _zAvailable from publisher's website |
999 |
_c16484143 _d16484143 |